These findings suggest that the reduction of collagen observed in our model may be an indirect effect of GRP94 inhibition, which decreases M2-like macrophages in tumors, leading to a decrease in TGF-β in the tumor microenvironment. This evidence concerns the gene HSP90B1 and neoplasm.